Fundz

Bluestar Genomics, Inc. reported raising $69.3 Million in an initial SEC Form D filing, from an offering of $71.6 Million

PRIVATEJun 21, 2021$69.3M of $71.6M raised

Amount Raised

$69.3 Million

$69.3 Million sold, per SEC Form D (first sale Jun 21, 2021)

Round Type

Venture

San DiegoBiotechnology

Quick answer

Bluestar Genomics, Inc. raised $69.3 Million in a funding round, dated June 21, 2021. Bluestar Genomics, Inc. is based in San Diego, California, United States.

How much did Bluestar Genomics, Inc. raise?
Bluestar Genomics, Inc. raised $69.3 Million in a funding round on June 21, 2021.
What does Bluestar Genomics, Inc. do?
Bluestar Genomics develops next-generation epigenomic approaches to detect deadly cancers, like pancreatic, early when curative therapies are possible.
Where is Bluestar Genomics, Inc. based and how big is it?
Bluestar Genomics, Inc. is based in San Diego, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Bluestar Genomics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • BobcatBio raised $27M on August 5, 2021.
  • Encellin raised $5.9M (Seed) on August 5, 2021.
  • Courier Health raised $4M (Seed) on August 5, 2021.
  • Apothewell raised $50K (Pre-Seed) on August 4, 2021.
  • Sonoma Biotherapeutics raised $265M (Series B) on August 4, 2021.
  • Alzamend Neuro raised an undisclosed amount on August 4, 2021.

Who to call at Bluestar Genomics, Inc., and when

A new round usually means Bluestar Genomics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bluestar Genomics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bluestar Genomics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bluestar Genomics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bluestar Genomics, Inc.

Location

10578 SCIENCE CENTER DRIVE

San Diego, California, United States

About

Bluestar Genomics develops next-generation epigenomic approaches to detect deadly cancers, like pancreatic, early when curative therapies are possible. Founded based on the work of Dr. Stephen Quake, Bluestar Genomics combines novel epigenomic technologies with its innovative machine learning architecture to tackle the most urgent challenges such as cancer detection. Leveraging the ease of liquid biopsy technologies, the company’s cell-free DNA-based assays are targeting early cancer detection using simple and noninvasive blood draws to improve outcomes and save lives. Led by a team with decades of experience bringing products from concept to market, Bluestar Genomics is continuously seeking better ways to measure disease pathology and bring its technologies to patients, clinicians, scientists, and investors searching for tomorrow’s cures. www.bluestargenomics.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bluestar Genomics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Bluestar Genomics, Inc.'s next move

See what Strategic adds

Bluestar Genomics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.